Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 130:
131. The compound of claim 125, wherein the compound is of formula (II-A-2):, , or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof,
wherein:
R2 is NR2gR2h;
R2g is H, D, C1-C6 alkyl, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, C6-C14 alkyl, or 5- to 10-membered heteroaryl, wherein the C1-C6 alkyl, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, C6-C14 alkyl, or 5- to 10-membered heteroaryl is optionally substituted by 1, 2, 3, or 4 independently selected R2j substituents; and
R2h is H, D, C1-C6 alkyl, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, C6-C14 alkyl, or 5- to 10-membered heteroaryl, wherein the C1-C6 alkyl, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, C6-C14 alkyl, or 5- to 10-membered heteroaryl is optionally substituted by 1, 2, 3, or 4 independently selected R2j substituents.